Published by Frank Prenesti on 19th March 2021
(Sharecast News) - Oxford Biomedica said that Sanofi's decision to terminate collaboration on a haemophilia treatment would have a "negligible" impact on revenue.
URL: http://www.digitallook.com/dl/news/story/31720410/...